Northwell’s Northern Westchester Hospital (NWH) in Mount Kisco has named Dr. Anna Komorowski as the chief of hematology and medical oncology. In her new role, Dr. Komorowski will be responsible for overseeing inpatient and outpatient hematology and cancer services at the hospital, with a focus on improving patient care, service quality, and program expansion. Additionally, she will lead oncology research efforts and enhance the department’s involvement in the internal residency program to drive the hospital’s growth and academic initiatives.
Having joined Northwell Health in 2017, Dr. Komorowski has held various positions within the organization, including medical director and regional director of the Westchester Northwell Health Cancer Institute (NHCI). She has been instrumental in advancing the breast cancer program at Northwell’s Manhattan Eye, Ear and Throat Hospital and has actively contributed to institutional leadership through participation in key committees focusing on areas such as transfusion oversight and medication safety. Dr. Komorowski has authored nearly 20 peer-reviewed publications in oncology, critical care, and internal medicine, with a focus on topics like breast cancer, immunotherapy, and cancer prevention.
Raised in a family of medical professionals, Dr. Komorowski earned her medical degree from the Medical University of Warsaw in Poland and completed her internal medicine residency at Wakefield Division Montefiore Medical Center. She further pursued a fellowship in hematology and medical oncology at New York Medical College. NWH, a 245-bed acute care hospital in Mount Kisco, New York, is part of Northwell Health and is known for its commitment to providing high-quality, person-centered care. With over 1,400 highly trained medical staff members, the hospital ensures that patients and their families receive treatment in a nurturing and respectful environment.
As the only hospital in Westchester County to receive Healthgrades’ 2024 America’s 250 Best Hospitals Award, NWH has established superior quality standards that exceed those set by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) National Hospital Quality Measures. These accolades reflect the hospital’s dedication to offering top-tier treatment to its patients. Dr. Komorowski’s appointment as the chief of hematology and medical oncology is poised to further strengthen NWH’s position as a leading provider of cancer care and research in the region.
- Dr. Anna Komorowski appointed as Chief of Hematology and Medical Oncology at Northwell’s NWH
- Her leadership to enhance patient care, service quality, and program growth at the hospital
- Dr. Komorowski’s contributions to oncology research and institutional leadership within Northwell Health
- NWH’s recognition as one of America’s 250 Best Hospitals and its commitment to providing high-quality care.
Tags: immunotherapy
Read more on westfaironline.com